Form 4: BioLife Solutions CHRO Sells Shares for Tax Obligations

BioLife Solutions' Chief Human Resources Officer, Sarah Aebersold, sold 217 shares of common stock for $26.74 per share to cover tax withholding obligations.

Summary

• Sarah Aebersold, Chief Human Resources Officer of BioLife Solutions Inc. (BLFS), reported a sale of common stock.
• The transaction involved the disposition of 217 shares of common stock.
• The shares were sold at a price of $26.74 per share.
• Following this transaction, Ms. Aebersold beneficially owns 76,952 shares of common stock.
• The sale was executed on November 25, 2025.
• This transaction was conducted under a Rule 10b5-1(c) trading plan, established on February 24, 2022.
• The purpose of the sale was to satisfy tax withholding obligations related to the vesting of restricted stock.

Sentiment

Score: 5

Explanation: The transaction is a routine, pre-planned sale for tax purposes related to restricted stock vesting. It is neutral in terms of company performance or outlook, reflecting standard executive compensation practices.

Positives

• Vesting of restricted stock indicates employee retention and compensation structure is functioning, aligning executive interests with shareholder value.

Negatives

• A small insider sale, even for tax purposes, slightly reduces direct insider ownership.

Future Outlook

NA

Management Comments

• The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Industry Context

This filing is a routine insider transaction and does not provide specific insights into broader industry trends or competitive landscape. It reflects standard compensation practices within publicly traded companies, where executives receive equity compensation that often leads to sales for tax purposes upon vesting.

Related Party Transactions

• The transaction involves an insider (Chief Human Resources Officer Sarah Aebersold) selling company stock, which is inherently a related party transaction.

Stakeholder Impact

• Shareholders: The sale of 217 shares is a very small fraction of the company's outstanding shares and Ms. Aebersold's total holdings, thus having a negligible direct impact on overall share dilution or market sentiment.
• Employees: The vesting of restricted stock and subsequent tax-related sale is a standard part of executive compensation, which can be seen as a positive for employee morale and retention if similar equity programs are in place.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-planned sale of a small number of shares by an executive to cover tax obligations related to restricted stock vesting. Such transactions are common and generally do not reflect a change in the executive's confidence in the company or its future prospects. Given the nature and size of the transaction, it is not considered a material event that would warrant a change in investment recommendation. Investors should focus on the company's fundamental performance and broader market conditions rather than this specific insider sale.

Keywords

BioLife Solutions, BLFS, Form 4, Insider Trading, Stock Sale, Sarah Aebersold, Chief Human Resources Officer, 10b5-1 Plan, Tax Withholding, Restricted Stock